The shares of Acasti Pharma Inc. (NASDAQ: ACST) saw a sharp rise when the company reported that its clinical studies were making substantial progress. The
Acasti Pharma Inc. (ACST) shares were rising 22.04% to trade at $0.659 in after-hours at last check. As of the last check, shares of Ascasti
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.